(1′S,2S,2′R,3S)-2′-(N-Benzyl-N-mesitylenesulfonylamino)-1′-phe-
nylpropyl 2-(tert-butyldiphenylsilyloxy)-3-hydroxy-3-piperonylthi-
olpropionate, 13b: 103 mg, 85%; HPLC Rt (20% EtOAc in hexane)
20 min; Rf (20% EtOAc in hexane) 0.34; [R]D +33.8 (c 1.30,
CHCl3); νmax (neat)/cm-1 3519, 1685, 1604, 1319; 1H NMR δ (250
MHz, CDCl3) 7.55-7.45 (4H, m), 7.40-7.20 (11H, m), 7.15 (1H,
t, J ) 8.2 Hz), 7.00 (2H, t, J ) 7.8 Hz), 6.81 (2H, s), 6.62 (2H, d,
J ) 8.4 Hz), 6.45 (1H, d, J ) 8.0 Hz), 6.31 (1H, s), 6.18 (1H, d,
J ) 8.0 Hz), 5.86 (2H, d, J ) 3.5 Hz), 4.75 (1H, d, JA-B ) 16.2
Hz), 4.62 (1H, d, J ) 9.6 Hz), 4.49 (1H, br s), 4.34 (1H, d, JA-B
) 16.2 Hz), 4.29 (1H, d, J ) 4.6 Hz), 4.13 (1H, dq, J ) 9.6 and
6.8 Hz), 2.30 (3H, s), 2.25 (6H, s), 1.13 (3H, d, J ) 6.8 Hz), 1.07
(9H, s); 13C NMR δ (90.5 MHz, CDCl3) 197.3 (C), 147.1 (C), 146.9
(C), 142.2 (C), 140.5 (2C), 139.8 (C), 138.3 (C), 135.8 (2CH), 135.7
(2CH), 132.6 (C), 132.2 (C), 132.0 (2CH), 131.74 (C), 131.68 (C),
130.12 (CH), 130.08 (CH), 128.7 (2CH), 128.2 (2CH), 128.2 (2CH),
127.7 (2CH), 127.64 (2CH), 127.59 (2CH), 127.2 (CH), 127.0 (CH),
120.5 (CH), 107.6 (CH), 107.0 (CH), 100.7 (CH2), 82.5 (CH), 75.9
(CH), 56.0 (CH), 50.7 (CH), 47.2 (CH2), 26.8 (3CH3), 22.7 (2CH3),
20.8 (CH3), 19.1 (C), 17.8 (CH3); m/z (ESI-) 884 ([M - H]-, 92%),
411 (33), 367 (28), 265 (600); HRMS (FAB, 3-NOBA) [M + Na]+
found 908.3107, C51H55NO7S2SiNa requires 908.3087.
s), 6.72 (2H, d, J ) 7.8 Hz), 4.84 (1H, d, JA-B ) 16.3 Hz), 4.71
(1H, d, J ) 9.2 Hz), 4.44 (1H, d, JA-B ) 16.3 Hz), 4.25 (1H, d, J
) 3.2 Hz), 4.21 (1H, dq, J ) 9.2 and 6.8 Hz), 3.52-3.45 (1H, m),
2.30 (9H, s), 1.42-1.39 (1H, m), 1.23 (3H, d, J ) 6.8 Hz), 1.15
(9H, s), 1.09 (1H, ddd, J ) 13.8, 9.8, and 4.9 Hz), 0.75 (1H, ddd,
J ) 13.8, 9.2, and 3.3 Hz), 0.62 (3H, d, J ) 6.5 Hz), 0.50 (3H, d,
J ) 6.5 Hz); 13C NMR δ (90.5 MHz, CDCl3) 198.6 (C), 142.2
(C), 140.5 (2C), 139.9 (C), 138.4 (C), 135.8 (2CH), 135.7 (2CH),
132.8 (C), 132.8 (C), 132.0 (2CH), 131.8 (C), 130.2 (CH), 130.1
(CH), 128.5 (2CH), 128.22 (2CH), 128.15 (2CH), 127.9 (2CH),
127.7 (2CH), 127.6 (2CH), 127.2 (CH), 127.0 (CH), 82.3 (CH),
72.3 (CH), 56.2 (CH), 50.7 (CH), 47.5 (CH2), 40.0 (CH2), 26.9
(3CH3), 23.9 (CH), 23.1 (CH3), 22.8 (2CH3), 21.2 (CH3), 20.8
(CH3), 19.3 (C), 17.8 (CH3); m/z (ESI-) 820 ([M - H]-, 100%),
288 (4); HRMS (ESI-) [M - H]- found 820.3540, C48H58NO5S2Si
requires 820.3520.
(1′S,2S,2′R,3S)-2′-(N-Benzyl-N-mesitylenesulfonylamino)-1′-phe-
nylpropyl 2-(tert-butyldiphenylsilyloxy)-3-hydroxy-4-methylthiol-
pent-4-eneoate, 13e: 98 mg, 89%, 93:7 diastereomeric mixture;
HPLC Rt (15% EtOAc in hexane) 18 min; Rf (20% EtOAc in
hexane) 0.45; [R]D +4.6 (c 1.3, CHCl3) (93:7 diastereomeric
mixture); νmax (neat)/cm-1 3521, 1684, 1603, 1495, 1321, 1152;
1H NMR δ (250 MHz, CDCl3) 7.65-7.55 (4H, m), 7.47-7.20
(11H, m), 7.11 (1H, t, J ) 7.7 Hz), 6.98 (2H, t, J ) 7.4 Hz), 6.82
(2H, s), 6.67 (2H, d, J ) 7.8 Hz), 4.81 (1H, d, JA-B ) 16.3 Hz),
4.68 (1H, d, J ) 9.4 Hz), 4.59 (1H, br s), 4.53 (1H, br s), 4.41
(1H, d, JA-B ) 16.3 Hz), 4.28 (1H, d, J ) 4.0 Hz), 4.20 (1H, dq,
J ) 9.4 and 6.7 Hz), 3.90 (1H, br t), 2.29 (3H, s), 2.27 (6H, s),
2.08 (1H, d, J ) 4.0 Hz), 1.25 (3H, s), 1.19 (3H, d, J ) 6.7 Hz),
1.12 (9H, s); 13C NMR δ (90.5 MHz, CDCl3) 196.9 (C), 142.2
(C), 140.7 (C), 140.5 (2C), 139.8 (C), 138.4 (C), 135.8 (2CH), 135.7
(2CH), 132.8 (C), 132.3 (C), 132.0 (2CH), 131.7 (C), 130.2 (CH),
130.1 (CH), 128.6 (2CH), 128.2 (2CH), 128.1 (2CH), 127.8 (2CH),
127.7 (2CH), 127.6 (2CH), 127.2 (CH), 126.9 (CH), 112.8 (CH2),
80.2 (CH), 77.1 (CH), 56.1 (CH), 50.8 (CH), 47.4 (CH2), 26.8
(3CH3), 22.8 (2CH3), 20.8 (CH3), 19.2 (C), 18.5 (CH3), 17.9 (CH3);
m/z (ESI-) 804 ([M - H]-, 100%), 415 (6); HRMS (ESI-) [M -
H]-, found 804.3224, C47H54NO5S2Si requires 804.3207.
(1′S,2S,2′R,3S)-2′-(N-Benzyl-N-mesitylenesulfonylamino)-1′-phe-
nylpropyl 2-(tert-butyldiphenylsilyloxy)-3-hydroxy-4-methylthiol-
pentanoate, 13c: 85 mg, 77%; HPLC Rt (10% EtOAc in hexane)
21 min; Rf (20% EtOAc in hexane) 0.52; [R]D -6.0 (c 1.5, CHCl3);
ν
max (neat)/cm-1 3567, 1685, 1603, 1495, 1322, 1153; 1H NMR δ
(250 MHz, CDCl3) 7.64-7.60 (4H, m), 7.47-7.20 (11H, m), 7.13
(1H, t, J ) 7.3 Hz), 7.01 (2H, t, J ) 7.8 Hz), 6.83 (2H, s), 6.71
(2H, d, J ) 7.1 Hz), 4.83 (1H, d, JA-B ) 16.3 Hz), 4.74 (1H, d, J
) 9.2 Hz), 4.45 (1H, d, JA-B ) 16.3 Hz), 4.32 (1H, d, J ) 3.5
Hz), 4.23 (1H, dq, J ) 9.2 and 6.8 Hz), 3.04 (1H, dt, J ) 7.8 and
3.8 Hz), 2.31 (9H, s), 1.60-1.35 (1H, m), 1.24 (3H, d, J ) 6.8
Hz), 1.14 (9H, s), 0.63 (3H, d, J ) 6.6 Hz), 0.50 (3H, d, J ) 6.6
Hz); 13C NMR δ (90.5 MHz, CDCl3) 198.3 (C), 142.2 (C), 140.5
(2C), 139.8 (C), 138.4 (C), 135.8 (2CH), 135.7 (2CH), 132.8 (C),
132.4 (C), 132.0 (2CH), 131.8 (C), 130.2 (CH), 130.1 (CH), 128.5
(2CH), 128.2 (4CH), 127.8 (2CH), 127.7 (2CH), 127.6 (2CH), 127.2
(CH), 126.9 (CH), 79.9 (CH), 79.7 (CH), 56.5 (CH), 50.7 (CH),
47.5 (CH2), 28.7 (CH), 26.9 (3CH3), 22.8 (2CH3), 20.8 (CH3), 19.2
(C), 18.8 (CH3), 18.3 (CH3), 17.6 (CH3); m/z (ESI-) 806 ([M -
H]-, 100%), 367 (7); HRMS (ESI-) [M - H]- found 806.3364,
C47H56NO5S2Si requires 806.3364.
Acknowledgment. We thank the EPSRC (DTA studentship
to S.F.) for financial support of this work.
Supporting Information Available: Preparation of 3 and
4, diagnostic data for glycolate aldol adducts 5a-10a and for
minor glycolate aldol adducts 14a-e, stereochemical assignment
(1′S,2S,2′R,3S)-2′-(N-Benzyl-N-mesitylenesulfonylamino)-1′-phe-
nylpropyl 2-(tert-butyldiphenylsilyloxy)-3-hydroxy-5-methylthiol-
hexanoate, 13d: 97 mg, 87%; HPLC Rt (10% EtOAc in hexane)
23 min; Rf (20% EtOAc in hexane) 0.51; [R]D -2.86 (c 1.75,
CHCl3); νmax (neat)/cm-1 3549, 1686, 1603, 1495, 1323, 1153; 1H
NMR δ (250 MHz, CDCl3) 7.67-7.59 (4H, m), 7.45-7.20 (11H,
m), 7.13 (1H, t, J ) 7.6 Hz), 7.01 (2H, t, J ) 7.3 Hz), 6.83 (2H,
1
data and CIF file for 5a, and H and 13C spectra for all new
compounds. This material is available free of charge via the
JO801720V
J. Org. Chem. Vol. 73, No. 24, 2008 9791